相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Frequency and Significance of HIV Infection among Patients Diagnosed with Thrombotic Thrombocytopenic Purpura
Melody Benjamin et al.
CLINICAL INFECTIOUS DISEASES (2009)
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
Marina Noris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura
April S. Kennedy et al.
TRANSFUSION (2009)
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura
Qurana F. Lewis et al.
TRANSFUSION (2009)
Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008
Loan Nguyen et al.
TRANSFUSION (2009)
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura
Karen K. Swisher et al.
TRANSFUSION (2009)
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2008)
Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
Ming Jin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry: The swiss connection
James N. George et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
Flora Peyvandi et al.
HAEMATOLOGICA (2008)
ADAMTS13 P475S polymorphism causes a lowered enzymatic activity and urea lability in vitro
M. Akiyama et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)
A. Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports
Karen K. Swisher et al.
HAEMATOLOGICA (2007)
Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity
Silvia Ferrari et al.
BLOOD (2007)
Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?
Christine M. Cserti et al.
JOURNAL OF CLINICAL APHERESIS (2007)
Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies
S. C. Meyer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Post-appendectomy thrombotic thrombocytopenic purpura: A case report and review of the literature
Mandy D. Robertson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Thrombotic thrombocytopenic purpura
JN George
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay:: comparison with other assay methods
JAK Hovinga et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the transfusion medicine/hemostasis clinical trials network with a systematic review of rituximab therapy for immune-mediated disorders
JN George et al.
JOURNAL OF CLINICAL APHERESIS (2006)
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome - III. An additional study of 57 consecutive patients, 2002-2005
MA Howard et al.
TRANSFUSION (2006)
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
DR Terrell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine
M Böhm et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay
K Kokame et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor:: in vitro inhibition of ADAMTS13 activity by hemoglobin
JD Studt et al.
BLOOD (2005)
Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients
T Raife et al.
TRANSFUSION (2004)
Post-operative thrombotic thrombocytopenic purpura: A review
TA Naqvi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement
P Coppo et al.
MEDICINE (2004)
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
XL Zheng et al.
BLOOD (2004)
Effect of awareness of a randomized controlled trial on use of experimental therapy
WF Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
V Bianchi et al.
BLOOD (2002)
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases
A Veyradier et al.
BLOOD (2001)
分享论文
